Population pharmacokinetics of gemcitabine and its metabolite in patients with cancer: Effect of oxaliplatin and infusion rate

British Journal of Clinical Pharmacology

Volumn 65, Issue 3, 2008, Pages 326-333

  Jiang, Xuemin ^a,b   Galettis, Peter ^c   Links, Matthew ^c   Mitchell, Paul L ^d   McLachlan, Andrew J ^a,e  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF CHICAGO   (United States)

^c ST GEORGE HOSPITAL   (Australia)

^d AUSTIN HOSPITAL   (Australia)

^e Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

Chemotherapy; dFdU; Gemcitabine; Metabolism; Oxaliplatin; Pharmacokinetics

Indexed keywords

2',2' DIFLUORODEOXYURIDINE; DRUG METABOLITE; GEMCITABINE; OXALIPLATIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG EFFECT; FEMALE; HUMAN; INFUSION RATE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CLINICAL TRIALS AS TOPIC; CROSS-OVER STUDIES; DEOXYCYTIDINE; DRUG INTERACTIONS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASMS; ORGANOPLATINUM COMPOUNDS;

EID: 40049093778     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.03040.x     Document Type: Article

References (26)